Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children's-led study in Nature ...
Radboudumc researchers used metabolomics to study cerebrospinal fluid (CSF) samples from tuberculous meningitis patients in Vietnam and Indonesia, with long-standing collaborators from Bandung and ...
Tuberculous meningitis is one of the most severe forms of tuberculosis and remains extremely difficult to treat. Even with recommended antibiotics and corticosteroids, at least one in four patients ...
Each year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in 1–2% of patients and is the most severe complication of tuberculosis, arising when ...
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and ...
Pediatric tuberculous meningitis (TBM) represents the most devastating form of childhood tuberculosis, arising when Mycobacterium tuberculosis traverses the blood–brain barrier to infect the meninges.
Findings from a Johns Hopkins Children’s Center study in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) ...
Tuberculous meningitis is a life-threatening form of extrapulmonary tuberculosis that demands prompt identification and treatment to prevent severe neurological damage. Diagnosis rests on integration ...
High-dose rifampin — 35 mg/kg daily — administered for 8 weeks showed no reduction in mortality rate compared with standard-dose rifampin — 10 mg/kg daily — in patients with tuberculous meningitis but ...
Your body's brain and spinal cord are surrounded by three layers of membranes known as the meninges. These protective membranes are vital for providing structural support, cushioning tissue, improving ...
Tuberculosis (TB) has been a serious health challenge globally. Its cases in India are also increasing the pressure on the health sector. TB is an infectious disease caused by Mycobacterium ...
From the sunbaked wastes of Arizona’s Navajo Reservation came dramatic news about the new TB drug, isoniazid (TIME, March 3). The report was carefully evaluated in the gleaming tower of Manhattan’s ...